FILE PHOTO: Tablets of Avigan are displayed during a photo opportunity at Fujifilm's headquarters in Tokyo. REUTERS/Issei Kato//File Photo
Fujifilm Holdings Corp will restart a clinical trial in Japan of its antiviral drug Avigan for the treatment of COVID-19, as per reports. The new study will involve about 270 patients and Fujifilm will aim to seek approval again in October 2021.
